Drugs / Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV)
Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV)
also known as
BRV-TV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01091298 | Apr → May 2010 | Rotavirus infection | Shantha Biotechnics Limited | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01091298 ↗ |
| Known as | BRV-TV | “Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine (BRV-TV)” NCT01091298 ↗ |
| Modality | Vaccine | “tetravalent rota virus vaccine” NCT01091298 ↗ |
| Route | Oral | “Single dose (0.5 mL) of the vaccine administered orally” NCT01091298 ↗ |